Cencora (COR) Competitors $288.31 +2.23 (+0.78%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$288.70 +0.38 (+0.13%) As of 08/1/2025 06:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock COR vs. ELV, MCK, CAH, HSIC, OMI, DHR, CVS, LH, NTRA, and ICLRShould you be buying Cencora stock or one of its competitors? The main competitors of Cencora include Elevance Health (ELV), McKesson (MCK), Cardinal Health (CAH), Henry Schein (HSIC), Owens & Minor (OMI), Danaher (DHR), CVS Health (CVS), Labcorp (LH), Natera (NTRA), and ICON (ICLR). These companies are all part of the "medical" sector. Cencora vs. Its Competitors Elevance Health McKesson Cardinal Health Henry Schein Owens & Minor Danaher CVS Health Labcorp Natera ICON Cencora (NYSE:COR) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, risk, earnings, profitability, analyst recommendations and valuation. Which has preferable earnings & valuation, COR or ELV? Elevance Health has higher revenue and earnings than Cencora. Elevance Health is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCencora$638.56M87.51$1.51B$8.6233.45Elevance Health$177.01B0.35$5.98B$23.5011.66 Do institutionals & insiders hold more shares of COR or ELV? 97.5% of Cencora shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 10.8% of Cencora shares are owned by company insiders. Comparatively, 0.3% of Elevance Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is COR or ELV more profitable? Elevance Health has a net margin of 2.83% compared to Cencora's net margin of 0.55%. Cencora's return on equity of 344.71% beat Elevance Health's return on equity.Company Net Margins Return on Equity Return on Assets Cencora0.55% 344.71% 4.26% Elevance Health 2.83%17.59%6.36% Does the media prefer COR or ELV? In the previous week, Elevance Health had 5 more articles in the media than Cencora. MarketBeat recorded 38 mentions for Elevance Health and 33 mentions for Cencora. Cencora's average media sentiment score of 1.51 beat Elevance Health's score of 1.44 indicating that Cencora is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cencora 29 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Elevance Health 36 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Is COR or ELV a better dividend stock? Cencora pays an annual dividend of $2.20 per share and has a dividend yield of 0.8%. Elevance Health pays an annual dividend of $6.84 per share and has a dividend yield of 2.5%. Cencora pays out 25.5% of its earnings in the form of a dividend. Elevance Health pays out 29.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cencora has raised its dividend for 15 consecutive years and Elevance Health has raised its dividend for 14 consecutive years. Which has more volatility and risk, COR or ELV? Cencora has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500. Comparatively, Elevance Health has a beta of 0.58, suggesting that its share price is 42% less volatile than the S&P 500. Do analysts rate COR or ELV? Cencora presently has a consensus price target of $309.83, suggesting a potential upside of 7.47%. Elevance Health has a consensus price target of $418.19, suggesting a potential upside of 52.57%. Given Elevance Health's higher probable upside, analysts clearly believe Elevance Health is more favorable than Cencora.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cencora 0 Sell rating(s) 3 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.75Elevance Health 0 Sell rating(s) 6 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.67 SummaryElevance Health beats Cencora on 10 of the 19 factors compared between the two stocks. Get Cencora News Delivered to You Automatically Sign up to receive the latest news and ratings for COR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding COR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart COR vs. The Competition Export to ExcelMetricCencoraMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$55.45B$7.18B$5.49B$20.63BDividend Yield0.75%2.90%4.73%3.67%P/E Ratio33.4564.1328.8329.01Price / Sales87.5133.83372.0766.10Price / Cash14.3925.7735.4522.82Price / Book71.368.618.274.43Net Income$1.51B$239.96M$3.25B$993.74M7 Day Performance-0.64%-5.48%-3.73%-3.39%1 Month Performance-0.95%-3.73%4.29%-2.10%1 Year Performance16.47%18.27%25.87%10.09% Cencora Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CORCencora4.3778 of 5 stars$288.31+0.8%$309.83+7.5%+17.9%$55.45B$638.56M33.4546,000Positive NewsUpcoming EarningsELVElevance Health4.9528 of 5 stars$284.91-1.4%$418.19+46.8%-48.5%$64.20B$189.25B12.13104,200Positive NewsMCKMcKesson4.5174 of 5 stars$709.79-0.3%$710.17+0.1%+11.0%$88.76B$359.05B27.4745,000Positive NewsUpcoming EarningsDividend IncreaseCAHCardinal Health4.685 of 5 stars$156.05-0.7%$158.07+1.3%+50.8%$37.25B$226.83B24.3548,900Positive NewsAnalyst DowngradeHSICHenry Schein4.1329 of 5 stars$71.23-0.3%$78.08+9.6%-6.6%$8.67B$12.67B22.2525,000Upcoming EarningsOMIOwens & Minor4.6451 of 5 stars$7.89+0.1%$11.60+47.0%-59.8%$609.12M$10.70B-1.6623,200Gap DownDHRDanaher4.9712 of 5 stars$204.11-0.7%$247.61+21.3%-29.8%$146.14B$24.01B43.4363,000Positive NewsCVSCVS Health4.9985 of 5 stars$60.16-0.9%$75.13+24.9%+4.2%$76.18B$372.81B14.37300,000Trending NewsEarnings ReportAnalyst ForecastOptions VolumeAnalyst RevisionLHLabcorp4.8252 of 5 stars$261.97-1.1%$285.00+8.8%+12.0%$21.96B$13.48B28.9670,000Insider TradeNTRANatera3.6987 of 5 stars$138.75-0.1%$183.76+32.4%+30.7%$18.97B$1.70B-94.484,434Trending NewsUpcoming EarningsInsider TradeICLRICON4.5302 of 5 stars$188.14+0.6%$219.54+16.7%-49.1%$15.18B$8.28B19.3341,900 Related Companies and Tools Related Companies ELV Competitors MCK Competitors CAH Competitors HSIC Competitors OMI Competitors DHR Competitors CVS Competitors LH Competitors NTRA Competitors ICLR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:COR) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cencora, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cencora With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.